H2A Admin Core
H2A 管理核心
基本信息
- 批准号:10084612
- 负责人:
- 金额:$ 26.51万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-09-09 至 2025-08-31
- 项目状态:未结题
- 来源:
- 关键词:AccountingAdvocateAfricaAfrica South of the SaharaAfricanAgeBiological Specimen BanksCell NucleusClinicalCollaborationsCommunicationCommunitiesComputer softwareCountryData CollectionDatabase Management SystemsDevelopmentDocumentationElectronic MailEnsureFaceGenerationsGoalsGrantHIVHepatitis BHepatitis B VirusHepatitis C virusHumanInfectionInterceptInternationalInterruptionLeadLeadershipLinkMalignant NeoplasmsMedicalMentorsMonitorOnline SystemsPatient RecruitmentsPatientsPeer ReviewPeriodicityPoliciesPreparationPrimary carcinoma of the liver cellsProblem SolvingProgress ReportsPublic RelationsPublicationsReportingResearchResearch PersonnelResourcesReview LiteratureRisk FactorsRoleSchistosoma mansonii infectionSenegalSiteStructureSupervisionTimeTrainingUgandaUniversitiesWorkchronic infectiondata harmonizationdata sharingexpectationhuman subject protectionmeetingsorganizational structureparticipant retentionprogramssymposiumweb site
项目摘要
Hepatocellular carcinoma (HCC) is a very common and lethal cancer in Africa, and as patients with HIV live
longer, the HCC burden may increase. In prior studies, our team identified chronic infection with hepatitis B
and C viruses (HBV, HCV), HIV and Schistosomiasis mansoni as independent risk factors for HCC. Compared
to the US, HCC in sub-Saharan Africa occurs at younger age and more advanced stage with survival of only
months. Proposed is an East and West African partnership between colleagues at Makerere University in
Uganda, Fann University in Senegal and Johns Hopkins University focused on HIV and hepatocellular
carcinoma (HCC) in Africa: The H2A Consortium. Building on long-standing collaborative research, mentoring
and clinical activities in both countries, our overarching goal is to reduce the heavy burden of HCC in sub-
Saharan Africa. We advocate investigating cancer interception strategies using appropriate medical treatments
to interrupt or reverse the impact of these HCC-causing infections. The Administrative and Coordinating
Core (ACC) will provide overall leadership for implementing the scientific agenda of the H2A consortium. Using
best practices from decades of international research collaboration, the H2A Consortium proposes an effective
organizational structure and strong leadership with a track record of international research collaboration. The
organizational framework builds upon the ongoing close working relationship between prior co-PIs from
Uganda and Hopkins and welcomes the Senegalese team as equal partners. The ACC will establish
transparent structures to support rigorous study oversight, effective communication, and efficient problem-
solving. The H2A Consortium effectively integrates ACC activities within a closely interacting Steering
Committee (SC) comprised of the Overall Co-Leaders and the Project /Core PIs. For each Project or Core, the
leadership represents an equitable partnership with PIs from each site sharing responsibilities. This leadership
nucleus is further supported by an External Advisory Panel (EAP) and a Community Advisory Panel (CAP),
with collaborative links to NCI Program leadership and other U54 Consortia sites. The impact of our integrated
research and capacity development activities will be establishment of the H2A Consortium as partnered
Centers of Excellence on HIV and HCC in East and West Africa.
肝细胞癌 (HCC) 是非洲一种非常常见且致命的癌症,随着艾滋病毒患者的生存
时间越长,HCC 负担可能会增加。在之前的研究中,我们的团队发现了乙型肝炎的慢性感染
C 病毒(HBV、HCV)、HIV 和曼氏血吸虫病是 HCC 的独立危险因素。比较的
与美国相比,撒哈拉以南非洲地区的 HCC 发生年龄更小,阶段更晚期,生存期仅为
几个月。提议在马凯雷雷大学的同事之间建立东非和西非伙伴关系
乌干达、塞内加尔范恩大学和约翰霍普金斯大学专注于艾滋病毒和肝细胞
非洲癌症 (HCC):H2A 联盟。建立在长期合作研究、指导的基础上
以及两国的临床活动,我们的总体目标是减轻亚裔 HCC 的沉重负担
撒哈拉非洲。我们主张使用适当的医疗方法研究癌症拦截策略
中断或扭转这些引起 HCC 的感染的影响。行政及协调
Core (ACC) 将为实施 H2A 联盟的科学议程提供全面领导。使用
根据数十年国际研究合作的最佳实践,H2A 联盟提出了一种有效的
组织结构和强有力的领导力以及国际研究合作的记录。这
组织框架建立在前联合PI之间持续密切的工作关系之上
乌干达和霍普金斯欢迎塞内加尔队成为平等伙伴。 ACC 将建立
透明的结构支持严格的研究监督、有效的沟通和高效的问题解决
解决。 H2A 联盟有效地将 ACC 活动整合到紧密互动的指导中
委员会 (SC) 由总体联合领导者和项目/核心 PI 组成。对于每个项目或核心,
领导力代表着与每个站点的 PI 之间的公平合作伙伴关系,分担责任。这个领导
nucleus 得到外部咨询小组 (EAP) 和社区咨询小组 (CAP) 的进一步支持,
与 NCI 项目领导层和其他 U54 联盟网站的协作链接。我们综合的影响
研究和能力开发活动将建立 H2A 联盟作为合作伙伴
东非和西非艾滋病毒和肝癌卓越中心。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Gregory D Kirk其他文献
Association of immunosuppression and HIV viremia with anal cancer risk in persons living with HIV in the United States and Canada.
美国和加拿大艾滋病毒感染者的免疫抑制和艾滋病毒病毒血症与肛门癌风险的关联。
- DOI:
- 发表时间:
2019 - 期刊:
- 影响因子:11.8
- 作者:
R. Hernández;L. Qin;Haiqun Lin;W. Leyden;Romain S. Neugebauer;K. Althoff;N. Hessol;Chad J. Achenbach;J. T. Brooks;M. Gill;S. Grover;M. Horberg;Jun Li;W. C. Mathews;Á. Mayor;P. Patel;Charles S Rabkin;A. Rachlis;Amy C. Justice;Richard D. Moore;Eric A. Engels;M. Silverberg;R. Dubrow;Constance A. Benson;Ronald J. Bosch;Gregory D Kirk;Kenneth H. Mayer;C. Grasso;Robert S. Hogg;P. Richard Harrigan;J. Montaner;B. Yip;Julia Zhu;K. Salters;Karyn Gabler;K. Buchacz;Jun Li;K. Gebo;Richard D. Moore;B. Rodriguez;M. Horberg;M. Silverberg;Jennifer E. Thorne;Charles S Rabkin;Joseph B. Margolick;Lisa P. Jacobson;Gypsyamber D'Souza;M. Klein;A. Kroch;Ann N. Burchell;Adrian Betts;Joanne D. Lindsay;R. Hunter;Á. Mayor;M. John Gill;S. Deeks;Jeffrey N. Martin;J. T. Brooks;M. Saag;M. Mugavero;James Willig;W. C. Mathews;Joseph J Eron;S. Napravnik;M. Kitahata;Heidi M Crane;D. Drozd;Timothy R. Sterling;David Haas;Peter F. Rebeiro;M. Turner;Amy C. Justice;R. Dubrow;David A. Fiellin;S. Gange;K. Anastos;K. Althoff;R. Mckaig;Aimee M. Freeman;Stephen E. Van Rompaey;Liz Morton;J. McReynolds;William Lober;Jennifer S. Lee;Bin You;B. Hogan;Jinbing Zhang;Jerry Jing;E. Humes;Sally B Coburn - 通讯作者:
Sally B Coburn
Designing and Validating a Novel Method for Assessing Delay Discounting Associated With Health Behaviors: Ecological Momentary Assessment Study
设计和验证一种评估与健康行为相关的延迟折扣的新方法:生态瞬时评估研究
- DOI:
10.2196/48954 - 发表时间:
2023-05-12 - 期刊:
- 影响因子:2.2
- 作者:
Amanda Luken;Jill A. Rabinowitz;Jonathan L Wells;D. Sosnowski;Justin C Strickland;Johannes Thrul;Gregory D Kirk;Brion S Maher - 通讯作者:
Brion S Maher
Multimorbidity Among Persons Living with Human Immunodeficiency Virus in the United States
美国人类免疫缺陷病毒感染者的多重发病率
- DOI:
10.1093/cid/cix998 - 发表时间:
2018-04-03 - 期刊:
- 影响因子:11.8
- 作者:
Cherise Wong;S. Gange;Richard D. Moore;Amy C. Justice;K. Buchacz;A. Abraham;Peter F. Rebeiro;J. Koethe;Jeffrey N. Martin;M. Horberg;Cynthia M Boyd;M. Kitahata;H. Crane;K. Gebo;M. Gill;M. Silverberg;F. Palella;P. Patel;H. Samji;J. Thorne;Charles S Rabkin;Á. Mayor;K. Althoff;Aimee M. Freeman;A. Cescon;Anita R Rachlis;Ben Rogers;B. Rodriguez;C. Grasso;Constance A. Benson;D. Drozd;D. Fiellin;D. Haas;Gregory D Kirk;J. Willig;J. Globerman;J. Brooks;J. Eron;J. Montaner;Karyn Gabler;K. Anastos;K. Mayer;L. Jacobson;Madison Kopansky;M. Klein;M. Turner;M. Mugavero;M. Saag;P. R. Harrigan;R. Dubrow;R. Hunter;Robert S. Hogg;Ronald J. Bosch;R. Mckaig;Sally S Bebawy;S. Rourke;S. Napravnik;S. Boswell;T. Sterling - 通讯作者:
T. Sterling
Baltimore oral epidemiology, disease effects, and HIV evaluation study (BEEHIVE) study protocol: a prospective cohort study
巴尔的摩口腔流行病学、疾病影响和 HIV 评估研究 (BEEHIVE) 研究方案:一项前瞻性队列研究
- DOI:
10.1186/s12903-024-04200-1 - 发表时间:
2024-04-10 - 期刊:
- 影响因子:2.9
- 作者:
D. Weatherspoon;Gregory D Kirk;D. Piggott;Vivek Thumbigere;Bruce A. Dye;Mark D Macek - 通讯作者:
Mark D Macek
Do contemporary antiretrovirals increase the risk of end‐stage liver disease? Signals from patients starting therapy in the North American AIDS Cohort Collaboration on Research and Design
北美艾滋病队列研究与设计合作中开始治疗的患者发出的现代抗逆转录病毒药物是否会增加终末期肝病的风险?
- DOI:
- 发表时间:
2021 - 期刊:
- 影响因子:2.6
- 作者:
Jim Young;V. Lo Re;H. Kim;Timothy R. Sterling;K. Althoff;K. Gebo;M. Gill;M. Horberg;Á. Mayor;Richard D. Moore;M. Silverberg;M. Klein;Constance A. Benson;Ronald J. Bosch;Gregory D Kirk;Vincent C Marconi;J. Colasanti;Kenneth H. Mayer;C. Grasso;Robert S. Hogg;Viviane D Lima;P. R. Harrigan;J. Montaner;B. Yip;Julia Zhu;K. Salters;K. Buchacz;Jun Li;K. Gebo;Richard D. Moore;Jeffrey Jacobson;M. Horberg;M. Silverberg;Jennifer E. Thorne;Todd Brown;Phyllis C. Tien;Gypsyamber D'Souza;Graham Smith;Mona Loutfy;Meenakshi Gupta;M. Klein;Charles Rabkin;A. Kroch;Ann N. Burchell;Adrian Betts;Joanne D. Lindsay;A. Nijhawan;Á. Mayor;M. Gill;Jeffrey N. Martin;J. T. Brooks;M. Saag;M. Mugavero;James Willig;Laura Bamford;Maile Karris;Joseph J Eron;S. Napravnik;M. Kitahata;Heidi M Crane;Timothy R. Sterling;David Haas;Peter F. Rebeiro;M. Turner;Kathleen McGinnis;Amy C. Justice;K. Althoff;S. Gange;Jennifer S. Lee;R. Mckaig;Aimee M. Freeman;Stephen E. Van Rompaey;Liz Morton;J. McReynolds;William Lober;B. Hogan;Bin You;E. Humes;R. Lang;Sally B Coburn;Lucas Gerace - 通讯作者:
Lucas Gerace
Gregory D Kirk的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Gregory D Kirk', 18)}}的其他基金
Baltimore Oral Epidemiology, Disease Effects, and HIV Evaluation Study (BEEHIVE)
巴尔的摩口腔流行病学、疾病影响和 HIV 评估研究 (BEEHIVE)
- 批准号:
10455501 - 财政年份:2020
- 资助金额:
$ 26.51万 - 项目类别:
Antiviral treatment as prevention for HBV- and HBV/HIV-associated hepatocellular carcinoma
抗病毒治疗预防 HBV 和 HBV/HIV 相关肝细胞癌
- 批准号:
10689163 - 财政年份:2020
- 资助金额:
$ 26.51万 - 项目类别:
Study of HIV Infection in the Etiology of Lung Disease (SHIELD) AIR: Air Pollution Impact on Respiratory Health in HIV
HIV 感染与肺部疾病病因学研究 (SHIELD) 空气:空气污染对 HIV 呼吸系统健康的影响
- 批准号:
10082701 - 财政年份:2020
- 资助金额:
$ 26.51万 - 项目类别:
Study of HIV Infection in the Etiology of Lung Disease (SHIELD) AIR: Air Pollution Impact on Respiratory Health in HIV
HIV 感染与肺部疾病病因学研究 (SHIELD) 空气:空气污染对 HIV 呼吸系统健康的影响
- 批准号:
10664953 - 财政年份:2020
- 资助金额:
$ 26.51万 - 项目类别:
Study of HIV Infection in the Etiology of Lung Disease (SHIELD) AIR: Air Pollution Impact on Respiratory Health in HIV
HIV 感染与肺部疾病病因学研究 (SHIELD) 空气:空气污染对 HIV 呼吸系统健康的影响
- 批准号:
10664953 - 财政年份:2020
- 资助金额:
$ 26.51万 - 项目类别:
Antiviral treatment as prevention for HBV- and HBV/HIV-associated hepatocellular carcinoma
抗病毒治疗预防 HBV 和 HBV/HIV 相关肝细胞癌
- 批准号:
10259886 - 财政年份:2020
- 资助金额:
$ 26.51万 - 项目类别:
Research Supplements to Promote Diversity in Health-Related Research
促进健康相关研究多样性的研究补充
- 批准号:
10643214 - 财政年份:2020
- 资助金额:
$ 26.51万 - 项目类别:
Baltimore Oral Epidemiology, Disease Effects, and HIV Evaluation Study (BEEHIVE)
巴尔的摩口腔流行病学、疾病影响和 HIV 评估研究 (BEEHIVE)
- 批准号:
10668433 - 财政年份:2020
- 资助金额:
$ 26.51万 - 项目类别:
相似海外基金
Hormonal contraception, pre-exposure prophylaxis, and HIV-1 protection
激素避孕、暴露前预防和 HIV-1 防护
- 批准号:
8626428 - 财政年份:2013
- 资助金额:
$ 26.51万 - 项目类别:
Hormonal contraception, pre-exposure prophylaxis, and HIV-1 protection
激素避孕、暴露前预防和 HIV-1 防护
- 批准号:
8537737 - 财政年份:2013
- 资助金额:
$ 26.51万 - 项目类别: